Okio Hino

Okio Hino

Auto-generated profile, based on publicly available information

Okio Hino

Department of Experimental Pathology, Cancer Institute, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2001 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
TKToshiyuki Kobayashi
Toshiyuki Kobayashi
OMOsamu Minowa
Osamu Minowa
YSYoshinobu Sugitani
Yoshinobu Sugitani
STSetsuo Takai
Setsuo Takai
HMHiroaki Mitani
Hiroaki Mitani
OHOkio Hino
Okio Hino
Tuberous sclerosis (TS) is characterized by the development of hamartomas in various organs and is caused by a germ-line mutation in either TSC1 or TSC2 tumor suppressor genes. From the symptomatic resemblance among TS patients, involvement of TSC1 and TSC2 products in a common pathway has been suggested. Here, to analyze the function of the Tsc1 product, we established a line of Tsc1 ( TSC1 homologue) knockout mouse by gene targeting. Heterozygous Tsc1 mutant ( Tsc1 +/− ) mice developed renal and extra-renal tumors such as hepatic hemangiomas. In these tumors, loss of wild-type Tsc1 allele was observed. Homozygous Tsc1 mutants died around embryonic days 10.5–11.5, frequently associated with neural tube unclosure. As a whole, phenotypes of Tsc1 knockout mice resembled those of Tsc2 knockout mice previously reported, suggesting that the presumptive common pathway for Tsc1 and Tsc2 products may also exist in mice. Notably, however, development of renal tumors in Tsc1 +/− mice was apparently slower than that in Tsc2 +/− mice. The Tsc1 knockout mouse described here will be a useful model to elucidate the function of Tsc1 and Tsc2 products as well as pathogenesis of TS.

22 April 2010 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
MKMakiko Kunogi
Makiko Kunogi
MKMasatoshi Kurihara
Masatoshi Kurihara
TITakako Shigihara Ikegami
Takako Shigihara Ikegami
TKToshiyuki Kobayashi
Toshiyuki Kobayashi
NSNoriko Shindo
Noriko Shindo
KSKuniaki Seyama
Kuniaki Seyama
Background: Birt–Hogg–Dubé syndrome (BHDS) is an inherited autosomal genodermatosis characterised by fibrofolliculomas of the skin, renal tumours and multiple lung cysts. Genetic studies have disclosed that the clinical picture as well as responsible germline FLCN mutations are diverse. Objectives: BHDS may be caused by a germline deletion which cannot be detected by a conventional genetic approach. Real-time quantitative polymerase chain reaction (qPCR) may be able to identify such a mutation and thus provide us with a more accurate clinical picture of BHDS. Methods: This study analysed 36 patients with multiple lung cysts of undetermined causes. Denaturing high performance liquid chromatography (DHPLC) was applied for mutation screening. If no abnormality was detected by DHPLC, the amount of each FLCN exon in genome was quantified by qPCR. Results: An FLCN germline mutation was found in 23 (63.9%) of the 36 patients by DHPLC and direct sequencing (13 unique small nucleotide alterations which included 11 novel mutations). A large genomic deletion was identified in two of the remaining 13 patients by qPCR (one patient with exon 14 deletion and one patient with a deletion encompassing exons 9 to 14). Mutations including genomic deletions were most frequently identified in the 3′-end of the FLCN gene including exons 12 and 13 (13/25=52.0%). The BHDS patients whose multiple cysts prompted the diagnosis in this study showed a very low incidence of skin and renal involvement. Conclusions: BHDS is due to large deletions as well as small nucleotide alterations. Racial differences may occur between Japanese and patients of European decent in terms of FLCN mutations and clinical manifestations.

15 February 2000 in Journal of Virology
Verified
Journal Article
Open access
PDF file
HAHiroshi Aoki
Hiroshi Aoki
JHJunpei Hayashi
Junpei Hayashi
MMMitsuhiko Moriyama
Mitsuhiko Moriyama
YAYasuyuki Arakawa
Yasuyuki Arakawa
OHOkio Hino
Okio Hino
Persistent hepatitis C virus (HCV) infection is a major cause of chronic liver dysfunction in humans and is epidemiologically closely associated with the development of human hepatocellular carcinoma. Among HCV components, core protein has been reported to be implicated in cell growth regulation both in vitro and in vivo, although mechanisms explaining those effects are still unclear. In the present study, we identified that members of the 14-3-3 protein family associate with HCV core protein. 14-3-3 protein bound to HCV core protein in a phosphoserine-dependent manner. Introduction of HCV core protein caused a substantial increase in Raf-1 kinase activity in HepG2 cells and in a yeast genetic assay. Furthermore, the HCV core–14-3-3 interaction was essential for Raf-1 kinase activation by HCV core protein. These results suggest that HCV core protein may represent a novel type of Raf-1 kinase-activating protein through its interaction with 14-3-3 protein and may contribute to hepatocyte growth regulation.

9 February 2004 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KOKazuo Okimoto
Kazuo Okimoto
JSJunko Sakurai
Junko Sakurai
TKToshiyuki Kobayashi
Toshiyuki Kobayashi
HMHiroaki Mitani
Hiroaki Mitani
YHYouko Hirayama
Youko Hirayama
OHOkio Hino
Okio Hino
A rat model of hereditary renal carcinoma (RC) was found in a rat colony of the Sprague–Dawley strain in Japan and named the “Nihon” rat. In heterozygotes, RCs, predominantly the clear cell type, develop from early preneoplastic lesions, which began to appear as early as 3 weeks of age, to adenocarcinomas by the age of 6 months. The Nihon rat is an example of a Mendelian dominantly inherited predisposition for development of RCs like the Eker ( Tsc2 gene mutant) rat. We have previously shown that the Nihon mutation was tightly linked to genes that are located on the distal part of rat chromosome 10. The order of the genes is the Eker ( Tsc2 gene (human 16p13.3)– Il3 gene–Nihon gene– Llgl1 locus– Myhse gene. We now describe a germ-line mutation in the Birt–Hogg–Dubé gene ( Bhd ) (human 17p11.2) caused by the insertion of a single nucleotide in the Nihon rat, resulting in a frameshift and producing a stop codon 26 aa downstream. We found that the homozygous mutant condition was lethal at an early stage of fetal life in the rat. We detected a high frequency of loss of heterozygosity (LOH) in primary RCs (10/11) at the Bhd locus and found a point mutation (nonsense) in one LOH-negative case, fitting Knudson's “two-hit” model. The Nihon rat may therefore provide insights into a tumor-suppressor gene that is related to renal carcinogenesis and an animal model of human BHD syndrome.

14 June 2006 in Cancer Science
Verified
Journal Article
Open access
PDF file
KSKazu Shiomi
Kazu Shiomi
HMHideaki Miyamoto
Hideaki Miyamoto
TSTatsuya Segawa
Tatsuya Segawa
YHYoshiaki Hagiwara
Yoshiaki Hagiwara
AOAkinobu Ota
Akinobu Ota
OHOkio Hino
Okio Hino
We have developed a novel enzyme‐linked immunosorbent assay (ELISA) system for the detection of N‐ERC/mesothelin in the serum of mesothelioma patients and have begun to examine its clinical usefulness. N‐ERC/mesothelin is a 31‐kDa protein that forms the N‐terminal fragment of the full‐length 71‐kDa ERC/mesothelin protein, and is physiologically secreted into the blood of mesothelioma patients where it can be detected using our sandwich ELISA containing two antibodies (rabbit polyclonal anti‐ERC/mesothelin antibody‐282 and mouse monoclonal antibody 7E7). Our ELISA system has thus far detected much higher serum levels of N‐ERC/mesothelin in mesothelioma patients than in healthy controls or patients with other lung or pleural diseases. In conclusion, N‐ERC/mesothelin is a promising candidate tumor marker for mesothelioma. (Cancer Sci 2006; 97: 928–932)

1 September 2000 in Japanese Journal of Cancer Research
Verified
Journal Article
Open access
PDF file
SMShuichi Majima
Shuichi Majima
KKKazunori Kajino
Kazunori Kajino
TFTomokazu Fukuda
Tomokazu Fukuda
FOFujio Otsuka
Fujio Otsuka
OHOkio Hino
Okio Hino
A modified AFLP (amplified fragment length polymorphism) method was employed to isolate genes differentially expressed in renal carcinogenesis of Tsc2 gene mutant (Eker) rats. One gene, selected for further investigation, was named “Niban” (“second” in Japanese), because it is the second new gene to be found after Erc (expressed in renal carcinoma) in our laboratory. Importantly, “Niban” is well expressed even in small primary rat Eker renal tumors, more than in progressed cell lines, and is also expressed in human renal carcinoma cells, but not in normal human or rat kidneys. Chromosome assignment was to RNO 13 in the rat, and HSA 1. This “Niban” gene is a candidate as a marker for renal tumor, especially early‐stage renal carcinogenesis.